SpringWorks Therapeutics, Inc.(SWTX) News

Date	Title
Nov 1	SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting